The subtle hypoxia underlying chronic cardiovascular disease is an attractive target for PET imaging, but the lead hypoxia imaging agents 64 CuATSM and 18 FMISO trapped only at extreme levels of hypoxia and hence are insufficiently sensitive for this purpose. We have therefore sought an analog of 64 CuATSM better suited to identify compromised but salvageable myocardium, validated using parallel biomarkers of cardiac energetics comparable to those observed in chronic cardiac ischemic syndromes.
INTRODUCTION
Hypoxia is a major factor in the pathology of cardiac ischemia. It is an important factor in the etiology of microvascular disease and cardiac hypertrophy, the prime determinant of the progression to heart failure, and the driver for compensatory angiogenesis [1] [2] [3] . In microvascular disease, while gross perfusion measured by MRI or scintigraphy may appear normal, the myocardium is hypoxically compromised at the cellular level 4 . This makes it an extremely difficult condition to diagnose, currently assigned by exclusion of other pathologies 5 . In hypertrophic myocardium, perfusion is also often "normal", but increased cell size, loss of ttubules, and scar means that increased diffusion distances critically limit oxygen delivery to mitochondria 6, 7 . To accurately characterise these conditions, imaging disparities between supply and demand for blood flow (ischemia), or O 2 (hypoxia), would be a potentially more useful approach than measuring poor perfusion per se 8 , but as yet, there are no methodologies sufficiently sensitive or specific for this purpose 9, 10 .
The PET tracer 64 CuATSM (R 1 =R 3 =R 4 =R 6 =Me, R 2 =R 5 =H, Fig 1) , exhibits rapid first pass uptake and fast clearance from normoxic tissues 11 and blood 12 , and rapid retention in hypoxic tissues to generate excellent images of tissue hypoxia within minutes. Experimentally, tissue 64 Cu accumulation from 64 CuATSM has been demonstrated only in extreme models of acute hypoxia and ischemia in isolated perfused hearts, and in regionally occluded canine myocardium in vivo 13, 14 , appearing to have a hypoxia-selective threshold of 1mm Hg or lower 11, 15 . While this degree of hypoxia is compatible with the survival and radio-resistance of cancer cells, for which it was designed, it is too severe for the long-term survival of cardiac myocytes (normal cardiac mitochondrial pO 2 is 10-35 mm Hg) 16 . In the one very small (seven patient) cardiac clinical trial that has been performed to date using 62 CuATSM, 62 Cu accumulation was only visualised in the myocardium of one patient with unstable angina, despite four of those patients exhibiting increased regional 18 The fundamental challenge, therefore, is to identify complexes which deposit their radiocopper payload within the myocardium at less extreme levels of hypoxia where its biochemistry is perturbed, but remains potentially salvageable. We reason that this target hypoxia "threshold" would be the point where there remains a degree of metabolic flexibility: a compromised but functional capacity for oxidative metabolism, but with sufficient ATP turnover to maintain ionic homeostasis and cellular integrity 9 . We have therefore performed a series of hypoxia titrations in the isolated heart to determine where this threshold lies using a panel of biochemical and biophysical assays. We then use a recently developed gamma detection array 17 to identify analogs of 64 CuATSM exhibiting greater sensitivity to hypoxia at this more relevant threshold.
MATERIALS AND METHODS

Reagents and Animals
All reagents were purchased from Sigma unless otherwise stated. Gases were supplied by BOC. Desired gas mixtures (O 2 /N 2 /CO 2 ) were achieved using a GSM-3 gas mixer (CWE Inc).
Male Wistar rats (275-300 g, Harlan), fed ad libitum, were used for all experiments. Animal procedures were in accordance with the Animals (Scientific Procedures) Act UK (1986).
Experimental Protocol
64
Cu was produced and used to radiolabel 2,3-butanedione bis (thiosemicarbazone) (ATS), diacetyl-bis(N4-ethylthiosemicarbazone) (ATSE), 2,3-butanedione bis(N4-by King's College London on May 18, 2015. For personal use only. jnm.snmjournals.org Downloaded from methylthiosemicarbazone) (ATSM) and 2,3-pentanedione bis(thiosemicarbazone) (CTS) as previously described 17 .
Rats (n = 6/group) were anesthetized with Sagatal (100 mg ip) and heparinized (200 IU ip), their hearts excised and cannulated in the Langendorff mode 18 . Hearts were perfused at constant flow (to simplify pharmacokinetic modeling) of 14 ml/min with a modified Krebs-Henseleit buffer (KHB) described previously 17 , gassed with 95% O 2 /5% CO 2 gas mixture, and contractile function was measured with a left ventricular balloon. Perfusion pressure was monitored by a pressure transducer in the arterial line. Hearts were paced at 300 beats/min throughout.
After 20 minutes, perfusate delivery was switched to a second reservoir containing KHB equilibrated with a gas mixture containing either 95%, 40%, 30%, 20%, 10% or 0% O 2 , balanced with N 2 and 5% CO 2 (for pH buffering), delivered by a gas mixer. 1 ml aliquots of coronary effluent were collected at regular intervals, and analysed for lactate content (YSI 2300 STAT Plus™ lactate analyser) to identify the onset of anerobic glycolysis, and creatine kinase content to monitor tissue necrosis. At the end of each experiment, hearts were snap-frozen in liquid nitrogen prior to Western blotting for HIF1α.
P Magnetic Resonance Spectroscopic Analysis (MRS)
Hearts were cannulated and inserted into a 15 mm glass MRS tube which was then placed in a custom-built MRS probe, as previously described 19 . 31 P MRS spectra were acquired on a Bruker Avance III 9.4T spectrometer using a 15 mm 31 P/ 1 H birdcage coil 20 . Shimming was performed on the 1 H lineshape of water (FWHM < 20 Hz). 31 P spectra were acquired with a pulse-acquire sequence using a 60 o flip angle, repetition time of 3.8 s and 64 scans (4 minutes per spectrum). The peak area of each metabolite was normalized to that of phosphocreatine (PCr) during normoxia. 
Profiling of Radiotracer Retention and Elution
In parallel groups of hearts, radiotracer uptake and pharmacokinetics were monitored using a custom built "triple gamma detector system" 17 , consisting of three orthogonally positioned leadshielded NaI detectors interrogating the arterial input line, the heart, and the venous outflow lines respectively, each connected to a modified GinaSTAR™ instant thin layer chromatography system (Raytest Ltd). 100 µl boluses containing 1 MBq radiotracer were injected into the arterial line after 10 minutes of normoxia, and 5 and 25 minutes of hypoxia. Time-activity curves generated by the GinaSTAR™ were imported into MATLAB® (MathWorks®). Data were decaycorrected and normalized to the maximum value of each group. Tissue retention was calculated as the residual activity in the heart 20 minutes post-injection as a percentage of the peak activity (% injected dose, %ID), as previously described 21 .
Western Blotting
Hearts were homogenized in 10 ml of homogenization buffer / g tissue (100 mM Tris pH 7.4, 2 mM sodium vanadate, 5 mM sodium fluoride, 1 x protease inhibitor cocktail tablet / 50 ml, 4 o C).
Equal volumes of homogenate and 2 x sodium dodecyl sulphate sample buffer were mixed before being loaded and separated by molecular weight using SDS-PAGE on a 10% polyacrylamide gel. Proteins were transferred to PVDF membranes (0.45 µm; GE Healthcare) using semi-dry blotting (Biorad). Blots were incubated for 2 hours at room temperature with hypoxia inducible factor (HIF-1α) antibody (rat polyclonal 5 µg/ml; Abcam). After incubation with HRP-labeled secondary antibodies, blots were developed using enhanced chemiluminescence (Amersham Pharmacia Biotech), with GAPDH as a loading control. HIF-1α and GAPDH expression were quantified through film-scanning and densitometry using Quantity One software (Biorad), with HIF-1α normalized to GAPDH.
Statistical Analysis
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RESULTS
All tracers examined deposited increasing amounts of radiocopper in the myocardium with increasingly severe hypoxia ( Fig 2) . Hypoxia selectivity was apparent within 5 minutes of onset (Fig 2a) , with significant 64 Cu retention in hearts injected with 64 Fig 4C) ; perfusion with more hypoxic buffers achieved no greater degree of ATP loss. Sugar and inorganic phosphates were not elevated by hypoxia after 5 minutes, but accumulated after 25 minutes perfusion with 20% O 2 (116 ± 37% versus 60 ± 18% and 49.8 ± 22.2% versus 13.8 ± 10.3% respectively; p<0.05).
While lactate washout was evident after 25 minutes of perfusion with 30% O 2 KHB, (0.21 ± 0.07 versus 0.01 ± 0.02 nmol during normoxia; p<0.05 ( Fig 5A) , it increased further with 20% O 2 KHB to a near-maximal value of 0.46 ± 0.11 (p<0.05). There was no evidence of creatine kinase leakage in any experimental group (data not shown). HIF-1α:GAPDH expression was elevated after 25 minutes of 30% O 2 KHB (0.278 ± 0.064 versus normoxic 0.175 ± 0.047; p<0.05, Fig   5B) , rising to a maximum of 0.61 ± 0.08 with 0% O 2 KHB. 
DISCUSSION
We recently demonstrated that 64 CuCTS and its analog 64 CuATS exhibit significantly greater hypoxia selectivity than the current lead compound 64 CuATSM in hearts perfused with hypoxic (0% O 2 ) buffer 17 . While a promising first step in the screening process, the key to the progression of this class of compounds is to identify complexes selective for levels of hypoxia which correlate with survivable (and treatable) cardiac disease 9, 10 . The relative sensitivities of these complexes to pathophysiologically relevant degrees of cardiac hypoxia were unknown. In this study, we identify a key hypoxic threshold that induces the major hallmarks of compromised but salvageable myocardium, which are: depressed contractile function, compromised PCr levels (but stable ATP levels), elevated HIF-1α expression, and increased but not maximal lactate washout (indicating residual oxidative reserve). At this threshold, achieved by perfusion with KHB saturated with 30%O 2 , we demonstrate that 64 CuCTS is the only complex among the four evaluated that provides a hypoxic:normoxic tissue contrast which would be exploitable for PET imaging 9 .
Our approach, of identifying parallel biomarkers of biochemical compromise to correlate against tracer uptake circumvents the difficult problem of describing tracer uptake in terms of absolute (and potentially arbitrary) intracellular oxygen concentrations, which are not only difficult to determine, but would also vary in relevance dependent upon oxygen demand, cardiac workload, and experimental model 16 . It also allows an immediate bioenergetic interpretation of the relevance of increased cardiac tracer retention, which is arguably translatable from the Langendorff perfused heart to the clinical situation. While changes in cardiac energetics can be quantified by 31 P spectroscopic imaging in clinical MR systems, the technical capacity and infrastructure to do so is not widespread, requires significant expertise, long acquisition times, and results in images of poor spatial resolution. Correlating PET tracer uptake with these key changes in cardiac energetics could therefore provide the same biochemical insight as 31 P MR by King's College London on May 18, 2015. For personal use only. jnm.snmjournals.org Downloaded from spectroscopic imaging, but exploit a technically simpler imaging approach with significantly greater temporal and spatial resolution (typical voxel sizes for clinical 64 Cu PET are 65 mm 3 22 , compared to 560 mm 3 for 31 P MRI at 3T) 23 .
We demonstrate that perfusion of hearts with 30% O 2 saturated KHB significantly depleted PCr, but was sufficient to maintain intracellular ATP and a degree of contractility. These characteristics mirror the reductions in PCr:ATP ratio previously demonstrated by 31 P MRS in patients with heart failure 24 , 25 and hypertrophic cardiomyopathy 26 , and correlate with declining left ventricular ejection fraction and increased mortality 27 . While moderate depletion of cardiac ATP has also been observed in patients diagnosed with hypertrophied and failing myocardium 28 , we used a less severe experimental threshold where PCr levels were compromised, but ATP levels were maintained to provide a more sensitive means of screening for diagnostically relevant hypoxia-selective complexes. Crucially, while 30% O 2 KHB increased lactate release by the heart, the rate of lactate washout only became maximal when hearts were perfused with KHB equilibrated with 20% O 2 and below, suggesting that at 30% O 2 there was still an aerobic metabolic reserve. At this key threshold, therefore, cardiac energetics and contractile function were compromised, but there was residual oxidative metabolism (and by inference mitochondrial function), suggesting that this degree of hypoxia would be sustainable chronically, making it a reasonable model of chronic cardiac ischemia.
30% O 2 was also the threshold for increased intracellular HIF-1α. As the key regulator of hypoxic gene expression, HIF-1α is responsible for numerous acute and chronic adaptive responses to tissue hypoxia, ranging from elevated glucose uptake and altered calcium handling to cardiac remodelling 29 , cardiomyopathy 30 , microvascular disease 31 and heart failure 32 , while chronic activation of HIF-1α in animal models leads to progressive heart failure and premature death 33 . Elevated HIF-1α was therefore a prerequisite for the threshold against which to evaluate our tracers. There is currently no non-invasive method for measuring Cu-ATSM when assessed after 2 or 16 hours, and that 64 Cu-acetate exhibits hypoxia selectivity in cultured cancer cells, suggesting that Cu-bis(thiosemicarbazone) complexes dissociate quickly in vivo, and that the resultant biodistribution observed by PET is that of free copper, questioning the validity of 64 CuATSM as a hypoxia tracer 34 . We and other groups have observed no such non-specific uptake up of ionic 64 Cu 2+ salts in normoxic or hypoxic myocytes in culture 15 , CHO cells 35 , or in isolated buffer perfused hearts 17, 21 . The wide variation in pharmacokinetics and early biodistributions that the different bis(thiosemicarbazones) have been shown to display, with some being hypoxia selective (ATSM, ATS, CTS etc.) and some not (PTSM, GTSM), some crossing the blood-brain barrier (GTSM, PTSM, ATSM etc.) and some not (ATS) 36, 37 , would also argue against a common non-selective mechanism of early tissue uptake. If such a mechanism does exist, it is likely dependent on tracer metabolism, and late recirculation of 64 Cu 2+ in copper transport proteins. We have recently shown that 64 CuATSM, 64 CuCTS and 64 CuATS all rapidly wash out of normoxic myocardium in rats in vivo to a stable low level within 5 minutes of injection, with no secondary "creep" of non-specific cardiac accumulation due to recirculation in the ensuing 30 minutes of imaging 17 , and no significant 64 Cu retention in healthy myocardium by biodistribution after 90 minutes. If secondary recirculation of 64 Cu occurs at later time points, the time between injection and imaging, and the relative in vivo stability of these complexes would be an important consideration in their use and by King's College London on May 18, 2015. For personal use only. jnm.snmjournals.org Downloaded from interpretation. Our study and many others which precede it 14, 17, 21 highlight the rapid hypoxia selectivity and tissue clearance of these tracers (within 5 minutes from normoxic myocardium both ex vivo, and in vivo) 17, 38 . We would therefore suggest that the rapid kinetics of these tracers should be exploited to minimise the potential impact of metabolism and recirculation by keeping imaging times short.
We have used 64 Cu in these experiments because its 12 hour half life allows us to perform several experiments from each batch. However, its half life is not ideal in terms of patient exposure, and with a positron yield of only 17.8%, nor is its dosimetry. In contrast, 62 Cu production does not require a cyclotron, has a half life of only 9.74 min and a 98% positron yield. The rapid kinetics that these tracers display would be very well suited to exploiting the dose-limiting advantages of 62 Cu radiolabelling clinically. We have employed isolated perfused hearts in this study because the model allows the accurate and reproducible induction of a range of hypoxic severity which would not be possible (or survivable or measurable) in vivo. It should of course be noted that tracer pharmacokinetics may be different in blood than in aqueous solution, and that the relationship between cardiac workload, arterial blood supply and tracer retention are likely to differ from that in vivo. We have, however, demonstrated the relative hypoxia selectivities of these tracers perfused under the same conditions, and 64 CuCTS appears to be a significant improvement upon 64 CuATSM in terms of hypoxia sensitivity.
We are currently unable to explain fully why 64 CuCTS exhibits better selectivity for low grade hypoxia than 64 CuATSM. Previous reports have suggested that hypoxia selectivity might be primarily governed by redox potential, yet CuATS, CuCTS, CuATSM and CuATSE all have the same redox potential (-0.59V versus Ag/AgCl 35 ) and different hypoxia selectivities. It therefore appears that while redox potential imparts hypoxia selectivity generally (the non-hypoxia selective tracer CuPTSM has a lower redox potential of -0.51V), subtle modification of redox 35 ). There is a limit to this tactic, however, since CuATS, which has the lowest lipophilicity, provided no further gain in hypoxia sensitivity at the 30% threshold. We speculate that the subtle balance between redox potential, lipophilicity and steric hindrance of redox and ligand exchange reactions governs residence time in the cell (and/or its intracellular localisation), and determine the rate at which each complex is reduced, reoxidised and dissociated to release its payload.
CONCLUSION
Hypoxia imaging has the capacity to augment current techniques for identifying viable but at-risk myocardium. Diffuse hypoperfusion associated with non-compensated hypertrophy or microvascular disease is currently difficult to diagnose by imaging perfusion; specifically imaging the resultant hypoxia by PET may be a useful alternative approach. While 64 CuATSM seems insufficiently sensitive to target myocardium compromised by such low-level survivable hypoxia, we identify 64 CuCTS as a potentially more suitable PET tracer in this regard. 
